Showing 1 - 10 of 3,129
We study cartels that operated in the US generic drug industry, leveraging quarterly Medicaid data from 2011-2018 and a difference-in-differences approach comparing the evolution of prices of allegedly collusive drugs with a group of competitive control drugs. Our analysis highlights (i) the...
Persistent link: https://www.econbiz.de/10012670921
consider competition in health insurance markets and physician services markets. We conclude by considering vertical restraints …
Persistent link: https://www.econbiz.de/10014025579
paper examines this tension over the past 10 years since modernisation of EU competition law. It looks at three types of … relevant product market, facilitating a finding of dominance. Some national competition authorities have followed in the …
Persistent link: https://www.econbiz.de/10013016118
context of greater or lesser innovation remain important, because competition law enforcement is not suited to playing a … structural role here. Instead, it can help to signal problems, establish principles and guard boundaries. Regulation and … competition are not alternatives, but complementary …
Persistent link: https://www.econbiz.de/10013299479
The incentives of pharmaceutical companies to innovate and how competition affects these incentives has been topical in … pandemic; and more specifically for competition authorities, as demonstrated for example by the role innovation played in the … research and development (R&D). Understanding these innovation incentives is relevant for a proper competition assessment where …
Persistent link: https://www.econbiz.de/10013227948
In this paper, we provide a very simple model to shed light on the issue of managed competition in mixed quasi … the proÖt-oriented Örm. Secondly, the socially-preferable form of managed competition is to introduce coproduction …
Persistent link: https://www.econbiz.de/10011734937
GLOBAL PRICE FIXING (2nd Edition) was released by Springer at the end of 2006. This note reproduces a 2002 review of the first edition of the book by Prof. Douglas Greer. It is reproduced with the permission of the publisher of the Review of Industrial Organization
Persistent link: https://www.econbiz.de/10012775648
products that are more directly affected by competition. However, at the product therapeutic area level, we find a reduction in … innovation by new entrants after the ruling in response to increased competition. Overall, these results are consistent with …
Persistent link: https://www.econbiz.de/10012818283
from one version of a drug to another to forestall generic competition. It can target distribution restrictions that brands … role to play. Antitrust is about competition, which lowers prices and increases choice. Consumers in the pharmaceutical …
Persistent link: https://www.econbiz.de/10012978113
Consumers suffer from high drug prices, which stem in large part from pharmaceutical companies’ anticompetitive games. This essay discusses the crucial role antitrust enforcement agencies can play in addressing pay-for-delay settlements and product hopping and draws lessons from this...
Persistent link: https://www.econbiz.de/10013215870